- Title
- Cutaneous myiasis: is Lucilia cuprina safe and acceptable for maggot debridement therapy?
- Creator
- Kingu, Howard J
- Creator
- Kuria, Simon K
- Creator
- Villet, Martin H
- Creator
- Mkhize, Jane N
- Creator
- Dhaffala, Adupa
- Creator
- Iisa, John M
- Subject
- To be catalogued
- Date Issued
- 2012
- Date
- 2012
- Type
- text
- Type
- article
- Identifier
- http://hdl.handle.net/10962/442649
- Identifier
- vital:74018
- Identifier
- DOI:10.4236/jcdsa.2012.22018
- Description
- Preservation of viable tissue is important in wound management. It is achieved by small, incremental removal of devitalised, necrotic and infected tissues. Maggot debridement therapy (MDT) is used in septic necrotic wounds that fail to respond to conventional modalities. MDT has relied on Lucilia cuprina, which consumes only necrotic tissues, as opposed to Lucilia cuprina, which devours both flesh and necrotic tissues. Recent findings have shown that L. cuprina consumes mainly necrotic and very small amounts of viable tissues and may be used in MDT where L. sericata is very rare or absent. Here we describe wound healing in a patient from rural South Africa with cutaneous myiasis. Our findings agree with workers who indicated that L. cuprina could be used in MDT.
- Format
- 4 pages
- Format
- Language
- English
- Relation
- Scientific Research
- Relation
- Kingu, H.J., Kuria, S.K., Villet, M.H., Mkhize, J.N., Dhaffala, A. and Iisa, J.M., 2012. Cutaneous myiasis: is Lucilia cuprina safe and acceptable for maggot debridement therapy?
- Relation
- Scientific Research volume 2012 number 1 1 14 2012
- Rights
- Publisher
- Rights
- Use of this resource is governed by the terms and conditions of the Scientific Research Publishing Statement (https://www.scirp.org/ )
- Hits: 46
- Visitors: 51
- Downloads: 5
Thumbnail | File | Description | Size | Format | |||
---|---|---|---|---|---|---|---|
View Details Download | SOURCE1 | Cutaneous Myiasis.pdf | 514 KB | Adobe Acrobat PDF | View Details Download |